1,25-Dihydroxyvitamin D downregulation of TGFα/EGFR expression and growth signaling: A mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 507-511

  Dusso, Adriana ^a   Cozzolino, Mario ^a   Lu, Yan ^a   Sato, Tetsuhiko ^a   Slatopolsky, Eduardo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EGFR; Parathyroid hyperplasia; Renal failure; TGF

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CALCITRIOL; ERLOTINIB; TRANSFORMING GROWTH FACTOR ALPHA;

CELL MEMBRANE; CONFERENCE PAPER; DOWN REGULATION; GENE OVEREXPRESSION; KIDNEY FAILURE; NONHUMAN; PARATHYROID HYPERPLASIA; PROPHYLAXIS; SIGNAL TRANSDUCTION; UREMIA;

CELL DIVISION; HUMANS; HYPERPLASIA; KIDNEY FAILURE; PARATHYROID GLANDS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA; VITAMIN D;

EID: 3042645056     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.061     Document Type: Conference Paper

References (31)

1. Parfitt A.M. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int. 52:1997;3-9
2. Slatopolsky E., Finch J., Denda M., Ritter C., Zhong M., Dusso A., MacDonald P.N., Brown A.J. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J. Clin. Invest. 97:1996;2534-2540
3. Silver J., Sela S.B., Naveh-Many T. Regulation of parathyroid cell proliferation. Curr. Opin. Nephrol. Hypertens. 6:1997;321-326
4. Gonzalez E.A., Martin K.J. Renal osteodystrophy: pathogenesis and management. Nephrol. Dial. Transplant. 10(Suppl. 3):1995;13-21
5. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., Wang Y., Chung J., Emerick A., Greaser L., Elashoff R.M., Salusky I.B. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl. J. Med. 342:2000;1478-1483
6. Cozzolino M., Dusso A.S., Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J. Am. Soc. Nephrol. 12:2001;2511-2516
7. Naveh-Many T., Rahamimov R., Livni N., Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J. Clin. Invest. 96:1995;1786-1793
8. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J. Clin. Endocrinol. Metab. 81:1996;1598-1606
9. Fukuda N., Tanaka H., Tominaga Y., Fukagawa M., Kurokawa K., Seino Y. Decreased 1, 25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J. Clin. Invest. 92:1993;1436-1443
10. Slatopolsky E. The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism. Nephrol. Dial. Transplant. 13(Suppl. 3):1998;3-8
11. Dusso A.S., Pavlopoulos T., Naumovich L., Lu Y., Finch J., Brown A.J., Morrissey J., Slatopolsky E. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int. 59:2001;855-865
12. Cozzolino M., Lu Y., Finch J., Slatopolsky E., Dusso A.S. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int. 60:2001;2109-2117
13. Gogusev J., Duchambon P., Stoermann-Chopard C., Giovannini M., Sarfati E., Drueke T.B. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uremic hyperparathyroidism. Nephrol. Dial. Transplant. 11:1996;2155-2162
14. Cozzolino M.L., Cordero Y., Finch J.B., Vidal J., Barbieri M., Slatopolsky M.A., Dusso E. A Regulation of parathyroid expression of TGFalpha and its receptor (EGFR) by Ca, P and vitamin D: relevance in the control of uremia-induced parathyroid growth. J. Am. Soc. Nephrol. 12:2001;763A
15. Cozzolino M., Lu Y., Finch J., Slatopolsky E., Dusso A.S. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int. 60:2001;2109-2117
16. Studer H., Derwahl M. Mechanisms of nonneoplastic endocrine hyperplasia - a changing concept: a review focused on the thyroid gland. Endocr. Rev. 16:1995;411-426
17. Busse D., Doughty R.S., Ramsey T.T., Russell W.E., Price J.O., Flanagan W.M., Shawver L.K., Arteaga C.L. Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity. J. Biol. Chem. 275:2000;6987-6995
18. Albanell J., Codony-Servat J., Rojo F., Del Campo J.M., Sauleda S., Anido J., Raspall G., Giralt J., Rosello J., Nicholson R.I., Mendelsohn J., Baselga J. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res. 61:2001;6500-6510
19. Zhu X.F., Liu Z.C., Xie B.F., Li Z.M., Feng G.K., Yang D., Zeng Y.X. EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells. Cancer Lett. 169:2001;27-32
20. Arteaga C.L. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J. Clin. Oncol. 19:2001;32S-40S
21. Cozzolino M.L.Y., Slatopolsky E., Dusso A. Specific inhibiton of EGFR-signaling prevents high phosphorus-induced parathyroid hyperplasia in renal failure. J. Am. Soc. Nephrol. 13:2002;193A
22. Tong W.M., Hofer H., Ellinger A., Peterlik M., Cross H.S. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. Oncol. Res. 11:1999;77-84
23. Gonzalez E.A., Disthabanchong S., Kowalewski R., Martin K.J. Mechanisms of the regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR 106-01 cells. Kidney Int. 61:2002;1627-1634
24. Awwad R., Humphrey L.E., Periyasamy B., Scovell W. Jr., Li W., Coleman K., Lynch M., Carboni J., Brattain M.G., Howell G.M. The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element. Oncogene. 18:1999;5923-5935
25. Clark A.J., Ishii S., Richert N., Merlino G.T., Pastan I. Epidermal growth factor regulates the expression of its own receptor. Proc. Natl. Acad. Sci. USA. 82:1985;8374-8378
26. Cordero J.B., Cozzolino M., Lu Y., Vidal M., Slatopolsky E., Stahl P.D., Barbieri M.A., Dusso A. 1, 25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. J. Biol. Chem. 277:2002;38965-38971
27. Brown A.J. Mechanisms for the selective actions of vitamin D analogues. Curr. Pharm. Des. 6:2000;701-716
28. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch. Dermatol. 125:1989;1647-1652
29. Derynck R., Goeddel D.V., Ullrich A., Gutterman J.U., Williams R.D., Bringman T.S., Berger W.H. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 47:1987;707-712
30. Busse D., Yakes F.M., Lenferink A.E., Arteaga C.L. Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance. Semin. Oncol. 28:2001;47-55
31. Tokumoto M., Tsuruya K., Fukuda K., Kanai H., Kuroki S., Hirakata H. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism. Kidney Int. 62:2002;1196-1207